Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Moazedi-Fuerst, FC; Kielhauser, SM; Brickmann, K; Hermann, J; Lutfi, A; Meilinger, M; Brezinschek, HP; Graninger, WB.
Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.
Scand J Rheumatol. 2014; 43(3):257-258
Doi: 10.3109/03009742.2013.869617
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Moazedi-Fürst Florentine
- Co-authors Med Uni Graz
- Brezinsek Hans-Peter
- Brickmann Kerstin
- Graninger Winfried
- Hermann Josef
- Kielhauser Sonja
- Lutfi Andre
- Meilinger Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Antibodies, Monoclonal, Murine-Derived - administration & dosage
- Antibodies, Monoclonal, Murine-Derived - adverse effects
- Disease Progression -
- Dose-Response Relationship, Drug -
- Drug Administration Schedule -
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Pulmonary Fibrosis - drug therapy
- Pulmonary Fibrosis - etiology
- Risk Assessment -
- Rituximab -
- Scleroderma, Systemic - complications
- Scleroderma, Systemic - diagnosis
- Scleroderma, Systemic - drug therapy
- Severity of Illness Index -
- Treatment Outcome -